| Chemical Name||perampanel|
|Dosage Form||Tablet (oral; 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg); Suspension (oral; 0.5 mg/mL) |
|Drug Class||Receptor antagonists|
Last updated on 5/11/2021
- Indicated for treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 4 years of age and older.
- Indicated for adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients with epilepsy 12 years of age and older.